JP2014521958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521958A5 JP2014521958A5 JP2014523039A JP2014523039A JP2014521958A5 JP 2014521958 A5 JP2014521958 A5 JP 2014521958A5 JP 2014523039 A JP2014523039 A JP 2014523039A JP 2014523039 A JP2014523039 A JP 2014523039A JP 2014521958 A5 JP2014521958 A5 JP 2014521958A5
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- cancer
- serous
- cells
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512576P | 2011-07-28 | 2011-07-28 | |
| US61/512,576 | 2011-07-28 | ||
| PCT/US2012/048452 WO2013016600A2 (en) | 2011-07-28 | 2012-07-27 | Methods and reagents for diagnosing conditions and characterization of tumor cells associated with serous fluids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521958A JP2014521958A (ja) | 2014-08-28 |
| JP2014521958A5 true JP2014521958A5 (enExample) | 2015-09-03 |
Family
ID=46650901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523039A Pending JP2014521958A (ja) | 2011-07-28 | 2012-07-27 | 胸腔内液若しくは漿液と関連する腫瘍細胞の特徴づけによる癌の診断方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140295426A1 (enExample) |
| EP (1) | EP2737317A2 (enExample) |
| JP (1) | JP2014521958A (enExample) |
| IL (1) | IL230687A0 (enExample) |
| TW (1) | TW201312117A (enExample) |
| WO (1) | WO2013016600A2 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6238856B2 (ja) * | 2014-08-25 | 2017-11-29 | シスメックス株式会社 | 尿中異型細胞の分析方法、尿分析装置および体液中異型細胞の分析方法 |
| CA3000438C (en) * | 2015-09-28 | 2024-05-14 | The Governing Council Of The University Of Toronto | Device for magnetic profiling of particles in a flow |
| US10696961B2 (en) | 2017-12-01 | 2020-06-30 | Global Life Sciences Solutions Usa Llc | Magnetic cell isolation techniques |
| CA3082861A1 (en) * | 2017-12-01 | 2019-06-06 | General Electric Company | Methods for cell enrichment and isolation |
| EP4073511A4 (en) * | 2019-12-12 | 2024-01-17 | University of Miami | MATERIALS AND METHODS FOR DETECTING EXTRACELLULAR VESICLES |
| EP4139440B1 (en) | 2020-04-22 | 2026-08-19 | Iovance Biotherapeutics, Inc. | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy |
| WO2021226061A1 (en) | 2020-05-04 | 2021-11-11 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy |
| EP4146793A1 (en) | 2020-05-04 | 2023-03-15 | Iovance Biotherapeutics, Inc. | Selection of improved tumor reactive t-cells |
| CA3195019A1 (en) | 2020-10-06 | 2022-04-14 | Maria Fardis | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
| WO2022076606A1 (en) | 2020-10-06 | 2022-04-14 | Iovance Biotherapeutics, Inc. | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
| JP2024501452A (ja) | 2020-12-11 | 2024-01-12 | アイオバンス バイオセラピューティクス，インコーポレイテッド | Ｂｒａｆ阻害剤及び／またはｍｅｋ阻害剤と併用した腫瘍浸潤リンパ球治療によるがん患者の治療 |
| JP2023554395A (ja) | 2020-12-17 | 2023-12-27 | アイオバンス バイオセラピューティクス，インコーポレイテッド | Ｃｔｌａ－４及びｐｄ－１阻害剤と併用した腫瘍浸潤リンパ球療法による治療 |
| US20240123067A1 (en) | 2020-12-17 | 2024-04-18 | Iovance Biotherapeutics, Inc. | Treatment of cancers with tumor infiltrating lymphocyte therapies |
| JP2024501845A (ja) | 2020-12-31 | 2024-01-16 | アイオバンス バイオセラピューティクス，インコーポレイテッド | 腫瘍浸潤リンパ球の自動化された産生のためのデバイス及びプロセス |
| JP2024509184A (ja) | 2021-03-05 | 2024-02-29 | アイオバンス バイオセラピューティクス，インコーポレイテッド | 腫瘍保存及び細胞培養組成物 |
| TW202304480A (zh) | 2021-03-19 | 2023-02-01 | 美商艾歐凡斯生物治療公司 | 腫瘤浸潤淋巴球（ｔｉｌ）中之與ｃｄ３９／ｃｄ６９選擇及基因剔除相關之ｔｉｌ擴增之方法 |
| EP4314253A2 (en) | 2021-03-25 | 2024-02-07 | Iovance Biotherapeutics, Inc. | Methods and compositions for t-cell coculture potency assays and use with cell therapy products |
| AU2022263418A1 (en) | 2021-04-19 | 2023-10-26 | Iovance Biotherapeutics, Inc. | Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies |
| US20240269180A1 (en) | 2021-05-17 | 2024-08-15 | Iovance Biotherapeutics, Inc. | Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy |
| CA3226942A1 (en) | 2021-07-28 | 2023-02-02 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors |
| CA3231018A1 (en) | 2021-09-09 | 2023-03-16 | Iovance Biotherapeutics, Inc. | Processes for generating til products using pd-1 talen knockdown |
| US20250000903A1 (en) | 2021-09-24 | 2025-01-02 | Iovance Biotherapeutics, Inc. | Expansion processes and agents for tumor infiltrating lymphocytes |
| US20230187042A1 (en) | 2021-10-27 | 2023-06-15 | Iovance Biotherapeutics, Inc. | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy |
| AU2022388729A1 (en) | 2021-11-10 | 2024-05-16 | Iovance Biotherapeutics, Inc. | Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes |
| JP2025503987A (ja) | 2022-01-28 | 2025-02-06 | アイオバンス バイオセラピューティクス，インコーポレイテッド | ペイロードを発現するように操作された腫瘍浸潤リンパ球 |
| EP4507704A1 (en) | 2022-04-15 | 2025-02-19 | Iovance Biotherapeutics, Inc. | Til expansion processes using specific cytokine combinations and/or akti treatment |
| WO2024011114A1 (en) | 2022-07-06 | 2024-01-11 | Iovance Biotherapeutics, Inc. | Devices and processes for automated production of tumor infiltrating lymphocytes |
| EP4565683A1 (en) | 2022-08-01 | 2025-06-11 | Iovance Biotherapeutics, Inc. | Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies |
| EP4612277A1 (en) | 2022-11-04 | 2025-09-10 | Iovance Biotherapeutics, Inc. | Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection |
| WO2024112571A2 (en) | 2022-11-21 | 2024-05-30 | Iovance Biotherapeutics, Inc. | Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom |
| IL325907A (en) | 2023-07-13 | 2026-03-01 | Iovance Biotherapeutics Inc | Cytokine encoding lentiviral vectors and uses thereof for making tumor infiltrating lymphocytes |
| WO2025019790A1 (en) | 2023-07-19 | 2025-01-23 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with trop-2 targeting adc |
| IL328125A (en) | 2023-11-06 | 2026-06-01 | Iovance Biotherapeutics Inc | Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies |
| WO2026035866A1 (en) | 2024-08-07 | 2026-02-12 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with a lag-3 inhibitor and a pd-1 inhibitor |
| WO2026050217A2 (en) | 2024-08-27 | 2026-03-05 | Iovance Biotherapeutics, Inc. | Engineered artificial antigen presenting cells and lipid nanoparticles for tumor infiltrating lymphocyte expansion |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939240A (en) | 1983-03-04 | 1990-07-03 | Health Research, Inc. | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy |
| JPH0763389B2 (ja) * | 1986-10-28 | 1995-07-12 | 協和醗酵工業株式会社 | 抗ヒト中皮細胞単クローン性抗体 |
| CA2065874C (en) | 1989-09-15 | 2001-12-11 | Joseph P. Brown | Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| CA2144750A1 (en) | 1992-09-17 | 1994-03-31 | Rolf Stahel | Tumor-specific antibodies and antigen |
| NO180658C (no) * | 1994-03-10 | 1997-05-21 | Oeystein Fodstad | Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner |
| US6660159B1 (en) | 1996-06-07 | 2003-12-09 | Immunivest Corporation | Magnetic separation apparatus and methods |
| US6136182A (en) | 1996-06-07 | 2000-10-24 | Immunivest Corporation | Magnetic devices and sample chambers for examination and manipulation of cells |
| AU3374597A (en) | 1996-06-07 | 1998-01-05 | Immunivest Corporation | Magnetic separation employing external and internal gradients |
| US6790366B2 (en) | 1996-06-07 | 2004-09-14 | Immunivest Corporation | Magnetic separation apparatus and methods |
| US6890426B2 (en) | 1996-06-07 | 2005-05-10 | Immunivest Corporation | Magnetic separation apparatus and methods |
| WO1999041613A1 (en) | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| US7282350B2 (en) | 1998-02-12 | 2007-10-16 | Immunivest Corporation | Labeled cell sets for use as functional controls in rare cell detection assays |
| US6623982B1 (en) | 1999-07-12 | 2003-09-23 | Immunivest Corporation | Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
| JP3766064B2 (ja) | 2001-02-12 | 2006-04-12 | イムニベスト・コーポレイション | 光学分析用の標本試料を収容するためのカートリッジ |
| WO2003019141A2 (en) * | 2001-08-23 | 2003-03-06 | Immunivest Corporation | Analysis of circulating tumor cells, fragments, and debris |
| GB2395270B (en) * | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
| EP1723428A2 (en) * | 2004-02-19 | 2006-11-22 | Yale University Corporation | Identification of cancer protein biomarkers using proteomic techniques |
| US20060024824A1 (en) * | 2004-07-16 | 2006-02-02 | Steven Woodside | Magnetic cell separation method |
| US7846743B2 (en) * | 2005-04-21 | 2010-12-07 | California Institute Of Technology | Uses of parylene membrane filters |
| EP1888238B1 (en) * | 2005-04-21 | 2014-08-13 | California Institute of Technology | Parylene membrane filters |
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| AU2007288620B2 (en) * | 2006-08-23 | 2012-08-30 | Korea Research Instititute Of Bioscience And Biotechnology | A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| EP2037265A1 (en) * | 2007-09-17 | 2009-03-18 | Adnagen AG | Solid phase cell isolation and/or enrichment method |
| WO2010102177A1 (en) * | 2009-03-06 | 2010-09-10 | Becton, Dickinson And Company | Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
-
2012
- 2012-07-27 WO PCT/US2012/048452 patent/WO2013016600A2/en not_active Ceased
- 2012-07-27 TW TW101127107A patent/TW201312117A/zh unknown
- 2012-07-27 US US14/235,185 patent/US20140295426A1/en not_active Abandoned
- 2012-07-27 EP EP12746193.7A patent/EP2737317A2/en not_active Withdrawn
- 2012-07-27 JP JP2014523039A patent/JP2014521958A/ja active Pending
-
2014
- 2014-01-28 IL IL230687A patent/IL230687A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lone et al. | Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | |
| Pang et al. | Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis | |
| Wei et al. | Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer | |
| Jiawei et al. | Magnetic bead-based adsorption strategy for exosome isolation | |
| Drucker et al. | Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients | |
| Li et al. | Exosomal proteins as potential markers of tumor diagnosis | |
| Hyun et al. | Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip | |
| Li et al. | Strategies for enrichment of circulating tumor cells | |
| Chung et al. | An electrical biosensor for the detection of circulating tumor cells | |
| Ning et al. | Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization | |
| WO2013016600A3 (en) | Methods for diagnosing cancer by characterization of tumor cells associated with pleural or serous fluids | |
| WO2015101163A1 (zh) | 抗hla-g的单克隆抗体偶联免疫磁珠在肿瘤细胞分选中的应用 | |
| Gao et al. | Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip | |
| US10094837B2 (en) | Cadherins as cancer biomarkers | |
| KR20230004496A (ko) | 생물학적 유체 샘플에서 세포외 소포체를 농축하는 방법 | |
| Li et al. | Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer | |
| Khondakar et al. | Prospects in cancer diagnosis: exosome-chip for liquid biopsy | |
| CN111830249A (zh) | 用于纯化分离及分析非典型循环肿瘤细胞的方法的用途及非典型循环肿瘤细胞的用途 | |
| CN106701684A (zh) | 一种高效率循环肿瘤细胞富集方法 | |
| Montoya Mira et al. | Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device | |
| Liu et al. | Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients | |
| Yi et al. | Exosomal proteomics: unveiling novel insights into lung cancer | |
| Manicone et al. | Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer | |
| Hu et al. | Enrichment and detection of circulating tumor cells by immunomagnetic beads and flow cytometry | |
| Guo et al. | Extracellular vesicles and their diagnostic and prognostic potential in cancer |